NON SMALL CELL LUNG CANCER STAGE III
Clinical trials for NON SMALL CELL LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop lung cancer from returning
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation (SBRT) can help keep early-stage non-small cell lung cancer from coming back. It included 13 people with stage I to IIIA disease. The main goal was to see how long they lived without their cancer getting wo…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New pill may keep stage III lung cancer from returning after chemo and radiation
Disease control OngoingThis study tests whether taking osimertinib daily after standard chemoradiation can delay cancer growth in people with stage III EGFR-mutant non-small cell lung cancer. About 216 participants who completed chemoradiation without progression will receive either osimertinib or a pl…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC
-
Gut bacteria may hold key to lung cancer therapy outcomes
Knowledge-focused OngoingThis study looks at whether bacteria from throat swabs, stool, and lung samples can help predict which patients with stage III lung cancer will have their cancer return during immunotherapy (durvalumab) after chemoradiation. Researchers will also study how antibiotics affect trea…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 20:03 UTC
-
Blood test may forecast lung cancer outcomes before surgery
Knowledge-focused OngoingThis study tracks 100 people with stage IIIA lung cancer who receive treatment before surgery. Researchers check for tumor DNA in the blood after treatment and before surgery to see if its disappearance is linked to longer survival. The goal is to learn if this blood test can hel…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC